Canada· CA-DIN-02534797

PENTACEL

A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus product containing haemophilus influenzae type b-prp + tetanus protein + filamentous haemagglutinin + poliovirus type 1 mahoney (inactivated), registered in Canada by SANOFI PASTEUR LIMITED. The same ATC class is registered in 8 of our 19 countries.

ATC J07CA06

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedPENTACELATCJ07CA06REGISTER NO.CA-DIN-02534797PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus is registered in 8 of 19 countries.

Countries holding a registration under ATC J07CA06 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 6 of them publish a price we can compare per daily dose

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus · ATC J07CA06

8 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
HAEMOPHILUS INFLUENZAE TYPE B-PRP + TETANUS PROTEIN + FILAMENTOUS HAEMAGGLUTININ + POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)
Manufacturer
SANOFI PASTEUR LIMITED
Country
Canada (CA)
ATC code
J07CA06
ATC class
Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2c5ba09-7b5d-467d-ae16-5d1a166540fd
GET /v1/drugs/f2c5ba09-7b5d-467d-ae16-5d1a166540fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02534797",
  "form": "SUSPENSION",
  "class": "Human",
  "routes": [
    "INTRAMUSCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J07CA06",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "102369",
  "strengths": [
    "10 MCG",
    "30 MCG",
    "20 MCG",
    "29 UNIT",
    "5 MCG",
    "15 LF",
    "7 UNIT",
    "3 MCG",
    "5 LF",
    "26 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "HAEMOPHILUS INFLUENZAE TYPE B-PRP",
    "TETANUS PROTEIN",
    "FILAMENTOUS HAEMAGGLUTININ",
    "POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)",
    "FIMBRIAE",
    "DIPHTHERIA TOXOID",
    "POLIOVIRUS TYPE 2 MEF1 (INACTIVATED)",
    "PERTACTIN",
    "TETANUS TOXOID",
    "POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED)",
    "PERTUSSIS TOXOID"
  ],
  "product_categorization": null
}

See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.